KPV – 10mg

KPV

This product is not intended for weight loss, human consumption, or veterinary use. It is sold for research purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.

What Is KPV Peptide?

KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH), recognized for its anti-inflammatory properties. Recent studies have explored its potential in modulating inflammatory responses in various rat models.(PubMed)

NuScience Peptides offers KPV peptide for sale in a 10mg lyophilized format, ideal for controlled laboratory research applications.

KPV Peptide in Stress-Induced Inflammatory Response

In a study by Liu et al., KPV peptide administration in scalded rats demonstrated a significant modulation of glucocorticoid receptor activity in hepatic cytosols, suggesting its role in regulating stress-induced inflammatory responses. (PubMed)

KPV Research Peptide and Kidney Receptor Function

Further research by the same group observed that KPV treatment could prevent the reduction of mineralocorticoid receptor binding capacity in kidney cytosols of rats subjected to severe scald injuries. (PubMed)

KPV Peptide and TNF-α Inhibition

Additionally, a study investigating the effects of a dimeric form of the KPV research peptide, (CKPV)₂, found that it effectively inhibited tumor necrosis factor-alpha (TNF-α) production in lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells and reduced circulating TNF-α levels in rats challenged with LPS. (PubMed)

KPV Peptide 10mg — Therapeutic Potential and Future Research

These findings collectively suggest that KPV and its derivatives may serve as potential therapeutic agents in managing inflammatory conditions. However, further studies are necessary to fully elucidate their mechanisms and efficacy in clinical settings.

Buy KPV peptide online from NuScience Peptides to advance your research into anti-inflammatory pathways with a verified, high-purity product.

References

• Liu, D. H., Su, Y. P., Zhang, W., Lou, S. F., Ran, X. Z., Gao, J. S., & Cheng, T. M. (2002). Downregulation of glucocorticoid receptors of liver cytosols and the role of the inflammatory cytokines in pathological stress in scalded rats. Burns, 28(4), 315–320. https://pubmed.ncbi.nlm.nih.gov/12052369/
• Liu, D. H., Su, Y. P., Zhang, W., Lou, S. F., Ran, X. Z., Gao, J. S., & Cheng, T. M. (2002). Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats. Critical Care Medicine, 30(3), 623–627. https://pubmed.ncbi.nlm.nih.gov/11990926/
• Catania, A., Gatti, S., Colombo, G., & Lipton, J. M. (2006). Inhibitory effects of the peptide (CKPV)₂ on endotoxin-induced host reactions. Peptides, 27(9), 2122–2129. https://pubmed.ncbi.nlm.nih.gov/16413580/
• Keremi, B., Lohinai, Z., Komora, P., Duhaj, S., Borsi, K., Jobbagy-Ovari, G., … & Varga, G. (2009). Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. Journal of Physiology and Pharmacology, 60(Suppl 7), 115–122. https://pubmed.ncbi.nlm.nih.gov/20388954/
• Gopalakrishnan, S., Tripathi, A., Tamiz, A. P., Alkan, S. S., & Pandey, N. B. (2012). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides, 35(1), 95–101. https://pubmed.ncbi.nlm.nih.gov/22401908/